{"id":44580,"date":"2022-06-01T18:01:54","date_gmt":"2022-06-01T16:01:54","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/the-worldwide-medical-device-reprocessing-industry-is-projected-to-reach-3-3-billion-by-2026-researchandmarkets-com\/"},"modified":"2022-06-01T18:01:54","modified_gmt":"2022-06-01T16:01:54","slug":"the-worldwide-medical-device-reprocessing-industry-is-projected-to-reach-3-3-billion-by-2026-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/the-worldwide-medical-device-reprocessing-industry-is-projected-to-reach-3-3-billion-by-2026-researchandmarkets-com\/","title":{"rendered":"The Worldwide Medical Device Reprocessing Industry is Projected to Reach $3.3 Billion by 2026 – ResearchAndMarkets.com"},"content":{"rendered":"
\n

DUBLIN–(BUSINESS WIRE)–The “Medical Device Reprocessing – Global Market Trajectory & Analytics”<\/a> report has been added to ResearchAndMarkets.com’s<\/strong> offering.\n<\/p>\n

<\/a><\/p>\n

\nThe global market for Medical Device Reprocessing estimated at US$1.8 Billion in the year 2022, is projected to reach a revised size of US$3.3 Billion by 2026, growing at a CAGR of 15.7% over the analysis period.\n<\/p>\n

\nReprocessing Support & Services, one of the segments analyzed in the report, is projected to grow at a 14.6% CAGR to reach US$2.1 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Reprocessed Medical Devices segment is readjusted to a revised 17.4% CAGR for the next 7-year period. This segment currently accounts for a 38.7% share of the global Medical Device Reprocessing market.\n<\/p>\n

\nThe U.S. Market is Estimated at $762.8 Million in 2022, While China is Forecast to Reach $466.8 Million by 2026<\/strong>\n<\/p>\n

\nThe Medical Device Reprocessing market in the U.S. is estimated at US$762.8 Million in the year 2022. The country currently accounts for a 41.1% share in the global market. China, the world’s second largest economy, is forecast to reach an estimated market size of US$466.8 Million in the year 2026 trailing a CAGR of 19.1% through the analysis period.\n<\/p>\n

\nAmong the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 11.5% and 14.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 14% CAGR while Rest of European market (as defined in the study) will reach US$139.3 Million by the close of the analysis period. Rising number of patients undergoing procedures in North America, Europe, and Japan, coupled with improved diagnosis, and screening in developing countries will help spur growth in the upcoming years.\n<\/p>\n

\nSelect Competitors (Total 162 Featured) –<\/strong>\n<\/p>\n